NASDAQ
CASI Pharmaceuticals, Inc. (CASI) has a eps (diluted) of $-2.56 as of Tuesday, December 31, 2024. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.